Legis Daily

SIFT Act of 2019

USA116th CongressHR-5421| House 
| Updated: 1/28/2020
Blaine Luetkemeyer

Blaine Luetkemeyer

Republican Representative

Missouri

Cosponsors (17)
Elise M. Stefanik (Republican)Eric A. "Rick" Crawford (Republican)Alexander X. Mooney (Republican)Emanuel Cleaver (Democratic)Rick W. Allen (Republican)Wm. Lacy Clay (Democratic)Billy Long (Republican)Jason Smith (Republican)James R. Baird (Republican)Ann Wagner (Republican)Rodney Davis (Republican)Glenn Grothman (Republican)James Comer (Republican)Sam Graves (Republican)Ted S. Yoho (Republican)Vicky Hartzler (Republican)Troy Balderson (Republican)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Stopping Illicit Trafficking Act of 2019 or the SIFT Act of 2019 This bill adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. The bill also creates a process to remove from schedule I certain fentanyl-related substances that do not have a high potential for abuse.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 12, 2019
Introduced in House
Dec 12, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 13, 2019
Referred to the Subcommittee on Health.
Jan 28, 2020
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
  • December 12, 2019
    Introduced in House


  • December 12, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • December 13, 2019
    Referred to the Subcommittee on Health.


  • January 28, 2020
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Crime and Law Enforcement

Related Bills

  • S 116-3148: Stopping Overdoses of Fentanyl Analogues Act
  • S 116-2701: Federal Initiative to Guarantee Health by Targeting Fentanyl Act
  • HR 116-2935: Stopping Overdoses of Fentanyl Analogues Act
  • S 116-1622: Stopping Overdoses of Fentanyl Analogues Act
  • HR 116-5771: Federal Initiative to Guarantee Health by Targeting Fentanyl Act
Administrative law and regulatory proceduresAdministrative remediesDrug trafficking and controlled substancesGovernment studies and investigationsResearch administration and funding

SIFT Act of 2019

USA116th CongressHR-5421| House 
| Updated: 1/28/2020
Stopping Illicit Trafficking Act of 2019 or the SIFT Act of 2019 This bill adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. The bill also creates a process to remove from schedule I certain fentanyl-related substances that do not have a high potential for abuse.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Dec 12, 2019
Introduced in House
Dec 12, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 13, 2019
Referred to the Subcommittee on Health.
Jan 28, 2020
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
  • December 12, 2019
    Introduced in House


  • December 12, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • December 13, 2019
    Referred to the Subcommittee on Health.


  • January 28, 2020
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Blaine Luetkemeyer

Blaine Luetkemeyer

Republican Representative

Missouri

Cosponsors (17)
Elise M. Stefanik (Republican)Eric A. "Rick" Crawford (Republican)Alexander X. Mooney (Republican)Emanuel Cleaver (Democratic)Rick W. Allen (Republican)Wm. Lacy Clay (Democratic)Billy Long (Republican)Jason Smith (Republican)James R. Baird (Republican)Ann Wagner (Republican)Rodney Davis (Republican)Glenn Grothman (Republican)James Comer (Republican)Sam Graves (Republican)Ted S. Yoho (Republican)Vicky Hartzler (Republican)Troy Balderson (Republican)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

Crime and Law Enforcement

Related Bills

  • S 116-3148: Stopping Overdoses of Fentanyl Analogues Act
  • S 116-2701: Federal Initiative to Guarantee Health by Targeting Fentanyl Act
  • HR 116-2935: Stopping Overdoses of Fentanyl Analogues Act
  • S 116-1622: Stopping Overdoses of Fentanyl Analogues Act
  • HR 116-5771: Federal Initiative to Guarantee Health by Targeting Fentanyl Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresAdministrative remediesDrug trafficking and controlled substancesGovernment studies and investigationsResearch administration and funding